Developing countries have limited healthcare resources and use different strategies to diagnose breast cancer. Most of the population depends on the public healthcare system …
Executive summary 1 This publication is a World Health Organization (WHO) guideline. A WHO guideline is any document, whatever its title, containing WHO recommendations about …
F Cardoso, D Spence, S Mertz, D Corneliussen-James… - The Breast, 2018 - Elsevier
Approximately 0.5 million people worldwide die from metastatic breast cancer (mBC) every year. This manuscript provides an overview on the status of mBC in several regions of the …
DR Youlden, SM Cramb, NAM Dunn, JM Muller… - Cancer …, 2012 - Elsevier
BACKGROUND: This paper presents the latest international descriptive epidemiological data for invasive breast cancer amongst women, including incidence, survival and mortality …
Background The incidence of cancer (excluding non-melanomatous skin cancers) is projected to rise from 17· 0 million to 26· 0 million between 2018 and 2040. A large …
Executive summary Availability of health technology is inversely related to health need. Although health-care systems in high-income countries make extensive use of technology …
JY Blay, S Boucher, B Le Vu, C Cropet, S Chabaud… - ESMO open, 2021 - Elsevier
Background The impact of the first coronavirus disease 2019 (COVID-19) wave on cancer patient management was measured within the nationwide network of the Unicancer …
H Wang, Y Li, SA Khan, Y Luo - Artificial intelligence in medicine, 2020 - Elsevier
Distant recurrence of breast cancer results in high lifetime risks and low 5-year survival rates. Early prediction of distant recurrent breast cancer could facilitate intervention and …
SY Kang, YS Kim, Z Kim, HY Kim, HJ Kim… - Journal of breast …, 2020 - ncbi.nlm.nih.gov
This article describes the breast cancer statistics in Korea, including the incidence, type of surgical procedure, stage, and molecular subtype, using the Korean Breast Cancer Society …